Early clinical predictors of fulminant myocarditis in pediatric patients: a retrospective cohort study

Jia Yuan1, Ming Li1, Li Ma2

  • 1Department of CICU, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.

PubMed

Insights

Early identification of fulminant myocarditis is crucial for timely treatment. Biomarkers such as N-terminal pro-B-type natriuretic peptide (NT-proBNP), cardiac troponin I (cTnI), alanine aminotransferase (ALT), and lactate (Lac) can predict its onset.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Biomarker Research

Background:

  • Fulminant myocarditis is a severe cardiac condition requiring prompt diagnosis.
  • Early identification is critical for improving patient outcomes and prognosis.
  • Clinical indicators and laboratory markers can aid in the early detection of fulminant myocarditis.

Purpose of the Study:

  • To identify clinical and laboratory indicators for the early detection of fulminant myocarditis.
  • To evaluate the predictive value of specific biomarkers in diagnosing fulminant myocarditis.
  • To compare patient characteristics between fulminant and non-fulminant myocarditis groups.

Main Methods:

  • Retrospective analysis of 269 acute myocarditis patients (2014-2023).
  • Division into fulminant (n=40) and non-fulminant (n=229) groups for comparison.
  • Multifactorial analysis and Receiver Operating Characteristic (ROC) curve analysis to identify predictive factors.

Main Results:

  • Older age was associated with fulminant myocarditis (P=0.015).
  • Fever and hypotension were more frequent in the fulminant group (P<0.05).
  • N-terminal pro-B-type natriuretic peptide (NT-proBNP), lactate (Lac), alanine aminotransferase (ALT), and cardiac troponin I (cTnI) were identified as early risk factors.

Conclusions:

  • NT-proBNP, cTnI, ALT, and Lac are significant predictors for early diagnosis of fulminant myocarditis.
  • Optimal predictive values established for NT-proBNP (2,783.5 pg/ml), ALT (34.5 U/L), cTnI (0.2 µg/ml), and Lac (3.05 mmol/L).
  • Early identification and diagnosis are vital for improving patient prognosis in fulminant myocarditis.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
258
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
168
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
367
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
275
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
203
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
405